Loading…
Huntington's disease
rare neurodegenerative disorder of the central nervous system characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia
Details
- Subclass of
- Huntington disease and related disorders, eye degenerative disease, genetic neurodegenerative disease with dementia, trinucleotide repeat disorder
- discoverer or inventor
- George Huntington
- drug or therapy used for treatment
- pimozide, (RS)-baclofen, perphenazine, ubidecarenone, tetrabenazine
- genetic association
- HTT
- has cause
- trinucleotide repeat expansion
- health specialty
- neurology
- ICD-9-CM
- 333.4
- ICPC 2 ID
- P70
- medical examination
- genetic testing
- mode of inheritance
- autosomal dominant
- named after
- George Huntington
- prevalence
- 0.000123
- symptoms and signs
- personality change, choreatic disease, weight loss, dementia
- time of discovery or invention
- 13 April 1872
- topic's main category
- Category:Huntington's disease
Connected on Wikidata
Subject of
- Journal of Huntington's Disease
- On Chorea
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease
- Longer than Expected: A Narrative Essay on the Letters of Samuel Huntington, 1779–1781
- THE PULSE OF PROGRESS: including a sketch of Jewish history. By Ellsworth Huntington. With a chapter on climatic changes, by G. C. Simpson. Scribners, 1926. pp. viii, 341. 21s
- Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease Huntington's Disease
- A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
- Individuals Patterns of Disclosure About Huntington s Disease (HD) and the Association With Adaptation to HD
- Atomoxetine and Huntington's Disease
- Neuroprotection by Cannabinoids in Huntington's Disease
Nothing in the MetaHistoryBook collection references this item yet.